Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass.

MLA

Petretto, Enrico, et al. “Integrated Genomic Approaches Implicate Osteoglycin (Ogn) in the Regulation of Left Ventricular Mass.” Nature Genetics, vol. 40, no. 5, May 2008, pp. 546–52. EBSCOhost, https://doi.org/10.1038/ng.134.

APA

Petretto, E., Sarwar, R., Grieve, I., Lu, H., Kumaran, M. K., Muckett, P. J., Mangion, J., Schroen, B., Benson, M., Punjabi, P. P., Prasad, S. K., Pennell, D. J., Kiesewetter, C., Tasheva, E. S., Corpuz, L. M., Webb, M. D., Conrad, G. W., Kurtz, T. W., Kren, V., … Cook, S. A. (2008). Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nature Genetics, 40(5), 546–552. https://doi.org/10.1038/ng.134

Chicago

Petretto, Enrico, Rizwan Sarwar, Ian Grieve, Han Lu, Mande K Kumaran, Phillip J Muckett, Jonathan Mangion, et al. 2008. “Integrated Genomic Approaches Implicate Osteoglycin (Ogn) in the Regulation of Left Ventricular Mass.” Nature Genetics 40 (5): 546–52. doi:10.1038/ng.134.